Thomas Heisser, MSc; Jens Kretschmann, MSc; Bernd Hagen, PhD; et al.
open access
JAMA Intern Med. 2023;183(3):183-190. doi:10.1001/jamainternmed.2022.6215
This cross-sectional study examines the prevalence of advanced colorectal neoplasms at least 10 years after a negative screening colonoscopy in repeated screening colonoscopy participants in Germany.
Nauzer Forbes, MD, MSc; B. Joseph Elmunzer, MD, MSc; Thibault Allain, PhD; et al.
open access
JAMA Intern Med. 2023;183(3):191-200. doi:10.1001/jamainternmed.2022.6394
This randomized clinical trial determines contamination rates after high-level disinfection and technical performance of duodenoscopes with disposable elevator caps compared with those with standard designs.
Luke P. Dawson, MBBS, MPH; Emily Nehme, MBiostats; Ziad Nehme, PhD; et al.
free access
JAMA Intern Med. 2023;183(3):203-211. doi:10.1001/jamainternmed.2022.6409
This economic evaluation uses cost-minimization analysis to estimate the cost savings of paramedic risk stratification of adult acute chest pain and point-of-care troponin testing.
-
Editorial
Are We Ready for Prehospital Troponin Testing?
Isabel R. Ostrer, MD; Tracy Y. Wang, MD, MHS, MSc
JAMA Intern Med
Soheila Aghlmandi, PhD; Florian S. Halbeisen, PhD; Ramon Saccilotto, MD; et al.
free access
JAMA Intern Med. 2023;183(3):213-220. doi:10.1001/jamainternmed.2022.6529
This randomized clinical trial investigates the effect of quarterly audit and feedback on antibiotic prescribing among primary care physicians in Switzerland with medium to high antibiotic prescription rates.
Less Is More
Eduard E. Vasilevskis, MD, MPH; Avantika Saraf Shah, MPH; Emily Kay Hollingsworth, MSW; et al.
free access
JAMA Intern Med. 2023;183(3):223-231. doi:10.1001/jamainternmed.2022.6545
This randomized clinical trial examines the safety and efficacy of reducing or stopping medications among inpatients 50 years or older.
Siwen Wang, MD; Yanping Li, PhD; Yiyang Yue, MS; et al.
open access
JAMA Intern Med. 2023;183(3):232-241. doi:10.1001/jamainternmed.2022.6555
This prospective cohort study investigates the association between healthy lifestyle factors prior to SARS-CoV-2 infection and risk of post鈥揅OVID-19 condition.
Elvira D鈥橝ndrea, MD, PhD; Deborah J. Wexler, MD, MSc; Seoyoung C. Kim, MD, ScD; et al.
open access
JAMA Intern Med. 2023;183(3):242-254. doi:10.1001/jamainternmed.2022.6664
This comparative effectiveness study evaluates cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP-4 inhibitors in adults with type 2 diabetes overall and at varying baseline HbA1c levels.